Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
Recruiting · NCT05068232 · Registry updated 2026-03-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Phase 2 | 2026-03-04 | NCT05068232 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Chicago | 326 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Chicago Medicine | Chicago | United States | 27 |
| University of Wisconsin Carbone Cancer Center | Madison | United States | 58 |